Cargando…

Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is associated with low-grade chronic inflammation. This was a retrospective case–control study. In the present study, the risk coefficients of neutrophil to lymphocyte ratio (NLR), high-sensitive C-reactive protein (hs-CRP), and mean platelet volume (MPV) in obese pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenhua, Li, Songyi, Lou, Xiaoming, Li, Dingheng, Wang, Fang, Zhang, Zhifen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302324/
https://www.ncbi.nlm.nih.gov/pubmed/35866809
http://dx.doi.org/10.1097/MD.0000000000029678
_version_ 1784751612470755328
author Liu, Wenhua
Li, Songyi
Lou, Xiaoming
Li, Dingheng
Wang, Fang
Zhang, Zhifen
author_facet Liu, Wenhua
Li, Songyi
Lou, Xiaoming
Li, Dingheng
Wang, Fang
Zhang, Zhifen
author_sort Liu, Wenhua
collection PubMed
description Polycystic ovary syndrome (PCOS) is associated with low-grade chronic inflammation. This was a retrospective case–control study. In the present study, the risk coefficients of neutrophil to lymphocyte ratio (NLR), high-sensitive C-reactive protein (hs-CRP), and mean platelet volume (MPV) in obese patients with PCOS were determined. This study was designed to investigate NLR, hs-CRP, and MPV levels in 68 obese patients with PCOS and 44 nonobese patients with PCOS, and our study group was matched with 47 obese and 43 nonobese controls, respectively. PCOS group had higher MPV, NLR, insulin, glucose, and HOMA-IR rates than those of the controls. Subgroup analyses revealed that the obese PCOS group had higher NLR, hs-CRP, and MPV levels compared to those of controls. The obese PCOS group had higher NLR, hs-CRP, and MPV levels compared to those of the nonobese PCOS group. The odds ratios and 95% confidence intervals of those variables (NLR, hs-CRP, MPV) were found significant (P < .05). NLR, hs-CRP, and MPV variables were found statistically significant in the analysis of receiver operating characteristics. Our study demonstrated that NLR, hs-CRP, and MPV levels are increased in patients with obese PCOS.
format Online
Article
Text
id pubmed-9302324
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93023242022-08-03 Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome Liu, Wenhua Li, Songyi Lou, Xiaoming Li, Dingheng Wang, Fang Zhang, Zhifen Medicine (Baltimore) Research Article Polycystic ovary syndrome (PCOS) is associated with low-grade chronic inflammation. This was a retrospective case–control study. In the present study, the risk coefficients of neutrophil to lymphocyte ratio (NLR), high-sensitive C-reactive protein (hs-CRP), and mean platelet volume (MPV) in obese patients with PCOS were determined. This study was designed to investigate NLR, hs-CRP, and MPV levels in 68 obese patients with PCOS and 44 nonobese patients with PCOS, and our study group was matched with 47 obese and 43 nonobese controls, respectively. PCOS group had higher MPV, NLR, insulin, glucose, and HOMA-IR rates than those of the controls. Subgroup analyses revealed that the obese PCOS group had higher NLR, hs-CRP, and MPV levels compared to those of controls. The obese PCOS group had higher NLR, hs-CRP, and MPV levels compared to those of the nonobese PCOS group. The odds ratios and 95% confidence intervals of those variables (NLR, hs-CRP, MPV) were found significant (P < .05). NLR, hs-CRP, and MPV variables were found statistically significant in the analysis of receiver operating characteristics. Our study demonstrated that NLR, hs-CRP, and MPV levels are increased in patients with obese PCOS. Lippincott Williams & Wilkins 2022-07-22 /pmc/articles/PMC9302324/ /pubmed/35866809 http://dx.doi.org/10.1097/MD.0000000000029678 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Research Article
Liu, Wenhua
Li, Songyi
Lou, Xiaoming
Li, Dingheng
Wang, Fang
Zhang, Zhifen
Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
title Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
title_full Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
title_fullStr Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
title_full_unstemmed Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
title_short Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
title_sort assessment of neutrophil to lymphocyte ratio, c-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302324/
https://www.ncbi.nlm.nih.gov/pubmed/35866809
http://dx.doi.org/10.1097/MD.0000000000029678
work_keys_str_mv AT liuwenhua assessmentofneutrophiltolymphocyteratiocreactiveproteinmeanplateletvolumeinobeseandnonobesepatientswithpolycysticovarysyndrome
AT lisongyi assessmentofneutrophiltolymphocyteratiocreactiveproteinmeanplateletvolumeinobeseandnonobesepatientswithpolycysticovarysyndrome
AT louxiaoming assessmentofneutrophiltolymphocyteratiocreactiveproteinmeanplateletvolumeinobeseandnonobesepatientswithpolycysticovarysyndrome
AT lidingheng assessmentofneutrophiltolymphocyteratiocreactiveproteinmeanplateletvolumeinobeseandnonobesepatientswithpolycysticovarysyndrome
AT wangfang assessmentofneutrophiltolymphocyteratiocreactiveproteinmeanplateletvolumeinobeseandnonobesepatientswithpolycysticovarysyndrome
AT zhangzhifen assessmentofneutrophiltolymphocyteratiocreactiveproteinmeanplateletvolumeinobeseandnonobesepatientswithpolycysticovarysyndrome